2024 Year-in-Review: Scientific Highlights from Current PharmaceuticalBiotechnology

This 2024 year-in-review article provides a comprehensive overview of the most cited articles published in Current Pharmaceutical Biotechnology (CPB) during the year across six key thematic areas: cancer, nanotechnology, antimicrobial agents, drug delivery, neurodegenerative diseases, and herbal and natural products. A total of twenty-nine high-impact studies have been selected and examined, each contributing meaningful advancements to the respective fields. The review highlights the application of phytochemicals in oncology, the versatility of nanomaterials in targeted therapies, innovations in antimicrobial strategies against resistant pathogens, intelligent drug delivery platforms, novel therapeutic approaches for neurodegenerative disorders, and the evolving role of botanicals in modern biopharmaceuticals. Through a narrative synthesis, the review illustrates how CPB has served as a vital platform for translational research, bridging molecular science and clinical innovation.